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ABSTRACT
Objective The Glasgow-Blatchford Bleeding Score
(GBS) was designed to identify patients with upper
gastrointestinal bleeding (UGIB) who do not require
hospitalisation. It may also help stratify patients unlikely to
benefit from intensive care.
Design We reviewed patients assigned a GBS in the
emergency room (ER) via a semiautomated calculator.
Patients with a score ≤7 (low risk) were directed to an
unmonitored bed (UMB), while those with a score of ≥8
(high risk) were considered for MB placement. Conformity
with guidelines and subsequent transfers to MB were
reviewed, along with transfusion requirement, rebleeding,
length of stay, need for intervention and death.
Results Over 34 months, 1037 patients received a GBS
in the ER. 745 had an UGIB. 235 (32%) of these patients
had a GBS ≤7. 29 (12%) low-risk patients were admitted
to MBs. Four low-risk patients admitted to UMB required
transfer to MB within the first 48 hours. Low-risk patients
admitted to UMBs were no more likely to die, rebleed,
need transfusion or require more endoscopic, radiographic
or surgical procedures than those admitted to MBs. No
low-risk patient died from GIB. Patients with GBS ≥8
were more likely to rebleed, require transfusion and
interventions to control bleeding but not to die.
Conclusion A semiautomated GBS calculator can be
incorporated into an ER workflow. Patients with a GBS ≤7
are unlikely to need MB care for UGIB. Further studies are
warranted to determine an ideal scoring system for MB
admission.

BACKGROUND
Patients with upper gastrointestinal bleeding
(UGIB) often present dramatically with
haematemesis or melena, hypotension and
even syncope. Because the aetiology of
bleeding is usually unknown and behaviour
uncertain at the time of admission, even
stable patients may be admitted to a high
acuity intensive care unit (ICU) with continuous patient monitoring and close nursing
care. However, most patients with GI bleeding
do not benefit from ICU care.1 Unnecessary ICU admissions increase costs and may
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Summary box
What is already know about this subject?
►► The Glasgow-Blatchford Bleeding Score (GBS) was

designed to identify low-risk upper gastrointestinal
bleeding (UGIB) patients who could be safely discharged from the emergency room. Subsequent
studies have shown that the GBS can help predict
rebleeding and need for transfusion.

What are the new findings?
►► This study shows that the GBS can be used to iden-

tify patients who do not need intensive monitoring
after admission.

How might it impact on clinical practice in the
foreseeable future?
►► Better understanding and use of predictive tools

could help reduce costs and resource allocation associated with treating UGIB.

impede access to other critically ill patients.
A recent analysis revealed broad variability
in ICU admission for UGIB among different
hospitals with no difference in outcomes.2
The Glasgow-
Blatchford Bleeding Score
(GBS) (online supplemental appendix A) was
designed to identify low-risk patients (score
<1) who could be safely discharged from the
emergency room (ER) after presenting with
UGIB.3 More recent studies have shown that
the GBS can predict a need for endoscopic
intervention,4 blood transfusion5 and urgent
endoscopy.6
The 2010 Toronto consensus guidelines
for UGIB advocated risk stratification in the
ER using the GBS or another validated tool.1
In 2012, the Swedish Medical Center began
including a GBS for all patients seen in the
ER with suspected UGIB. A ‘smart phrase’
was created in the hospital electronic health
record (EHR) (EPIC) to auto-populate relevant fields of the GBS in hope of improving
1
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its use. In addition to identifying very low-risk patients,
the score was also used to stratify lower-risk patients to
help reduce unnecessary ICU admissions. Analysis at 6
months revealed an 18% reduction in hospital expenses
for UGIB patients, about US$2000 per admission, with
no identifiable adverse outcomes, due in large part to
shorter lengths of stay and a decrease in admission to
ICU.7 The current study was undertaken to assess the
utility of the GBS to direct bed placement for patients
with UGIB.

METHODS:
We reviewed all patients over 18 years of age admitted
with symptoms of GI bleeding who were assigned a
GBS through Swedish Medical Center’s ER between 1
January 2015 and 31 October 2017. ER physicians were
asked to insert a GBS template within the body of their
admission note in the EHR. The template pulls recent
lab data and vital signs from the EHR to populate blood
urea nitrogen, haemoglobin level, systolic blood pressure
and pulse. Additional boxes address melena, syncope,
heart and liver disease history and are manually entered.
The EHR then calculates a score from 0 to 23 and places
it in the note. The score is accompanied by verbiage
suggesting admission to an unmonitored bed (UMB) for
patients with a score of 1–7, a monitored, intermediate
care (IMCU) bed for a score of 8–12 and ICU placement
for a score of 13 or higher, but also notes that physicians
may direct patients to a different unit based on clinical
judgement, (online supplemental appendix B).
Because of major similarities between IMCU and ICU
layout, equipment, staffing and other expenses, as well
as frequent flexing of ward designations based on census
and staffing, for analysis, admissions to both units were
grouped and designated MBs. General medical/surgical
ward and telemetry beds were considered UMBs, because
of similar staffing levels and cost.
All patients were admitted to hospitalist or intensivist
services with hospital-
based GI consultation. Urgent
endoscopy, within 24 hours of admission, was available
for all patients regardless of unit.
Using discharge diagnoses and endoscopic findings,
we identified patients who had or were likely to have had
an UGIB from any source. Those with bleeds distal to
the ligament of Treitze were analysed separately. Those
with uncertain bleeding were excluded. We categorised patients by their admitting GBS and determined
whether the admitting team followed recommendations
for bed assignment. For patients admitted outside of the
recommendations, the physicians’ notes were used to
determine the reason for bed placement and to review
the subsequent hospital course. Patients transferred
to a higher level of care within the first 48 hours were
also reviewed. We collected data on in-hospital mortality,
rebleeding, length of stay, transfusion requirement,
need for endoscopy and radiographic and surgical interventions. We reviewed in-hospital deaths to determine
2

Table 1 Patients admitted with UGIB
GBS
No
Median age
Female
LOS (average in hours)

≤7

≥8

P value

235

510

66

71

45%

50%

0.49

70

123

<0.01

0.02

Unit assignment by
protocol

206 (88%)

361 (71%)

0.03

Underwent urgent
endoscopy

150 (64%)

457 (90%)

0.01

Required transfusion

30 (13%)

360 (71%)

<0.01

Experienced rebleed

12 (5%)

71 (14%)

<0.01

Radiographic or surgical
intervention

2 (1%)

19 (4%)

0.03

Death

5 (2%)

20 (4%)

0.27

GBS, Glasgow-Blatchford Bleeding Score; LOS, length of stay;
UGIB, upper gastrointestinal bleeding.

if they resulted from GI bleeding and whether delay in
any intervention may have contributed to mortality. We
compared outcomes among groups who received bed
assignments within and outside of guidelines. We also
reviewed a separate cohort of patients during the same
period to calculate the actual use of the GBS for patients
with GIB symptoms.
The Fisher’s exact test was used for comparison of
categorical data, and an independent t-
test was used
for continuous data. Analyses were performed by using
GraphPad Prism statistical software, V.8 (GraphPad Software, La Jolla, California, USA). A p<0.05 was considered
as statistically significant.
RESULTS:
Over 34 months, 1037 patients were admitted through
the ER with a presumption of GIB and also received a
GBS. Of these, 745 had evidence of an UGIB, 244 were
determined to have had a lower gastrointestinal bleed
(LGIB), 23 had evidence of a small bowel bleed and for
25 no cause was identified. Among patients with UGIB,
235 (32%) had a GBS≤7 and 510 (68%) scored 8 or
higher. Twenty-nine (12%) patients in the low-risk group
were admitted to an MB (28 IMCU, 1 ICU) despite guidelines, (table 1). Among patients with scores>7, 149 (29%)
were admitted to UMBs while 287 went to IMCU and 74
to ICU. Among those who went to ICU 58 had GBS≥12,
representing 38% of that group. Low-risk patients were
more likely to receive a protocol directed admission than
high-risk patients (p=0.03).
Of the 745 patients suspected of having had an UGIB,
607 had this confirmed by upper endoscopy during that
admission. The remaining 138 individuals who did not
undergo endoscopy all presented with symptoms of
haematemesis, melena or profound anaemia and had a
documented upper endoscopy within the past year for
UGIB that revealed a likely source of recurrent bleeding,
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(erosive oesophagitis, alcoholic gastritis, etc). Average
time to endoscopy was 19 hours from admission and
access to endoscopy was not affected by unit placement.
Patients who had previous endoscopy that suggested
a likely source of current bleeding and were not felt to
need endoscopic therapy did not necessarily undergo
repeat endoscopy.
High-risk patients tended to be older, had longer admissions, were more likely to undergo urgent endoscopy,
transfusion and experience rebleeding as well as require
a non-endoscopic intervention to control bleeding than
low-risk patients, but were no more likely to die during
admission.
Because the GBS was not universally applied to all
patients presenting with UGIB symptoms, we sought to
understand rate of use of the GBS score among ER physicians. A separate group of all patients who presented to
the ER during the same period with the very specific International Classification of Diseases, tenth revision, clinical
modification (ICD-10-CM) codes K92.0 (haematemesis)
or K92.1 (melena) were reviewed, as this group represented patients who clearly would have qualified for
including a GBS. Of 644 patients, 405 (63%) received a
GBS in the ER while 239 (37%) were not scored. Among
47 ER physicians, GBS use ranged from 0% to 92% with
the top quartile averaging 81% and the lowest quartile
42%. The 405 patients with scores are included in the
study cohort. The remaining study patients received
other ICD-10-CM codes at admission.
Within the low-risk group, 29 patients were admitted
directly to an MB from the ER. Admission notes suggest
concern about rapid deterioration by the ER, hospitalist
or GI physician due to a history of cirrhosis and possible
oesophageal varices in 3 (10%) patients, other history of
alcohol abuse or withdrawal in 6 (21%), advanced age or
medical fragility in 7 (24%), very low haematocrit in 4
(14%), new or active bleeding in the ER in 4 (14%) and
active infection or sepsis in 2 (7%). No clear reason for
MB assignment could be identified for five patients. The
presence of liver disease, beyond its effect on the GBS,
did not appear to direct patients to an MB.
Low-
risk patients who were admitted to UMBs had
a lower average GBS than those admitted to MBs. In
order to better compare these groups, we excluded four
patients admitted to MBs for non-
bleeding symptoms
such as mental status changes or respiratory symptoms
who had a GBS <5 and compared the remaining 25 to a
score-matched group of patients (from 5 to 7) admitted
to UMBs, (table 2). MB patients were similar to UMB
patients in regard to age and gender. Within this cohort,
there was no difference in transfusions, rebleeding,
frequency of endoscopy or death. Patients admitted to
MBs stayed almost a day longer than those in UMBs,
but this did not reach significance. None of the low-risk
patients admitted to MBs required emergent intubation,
cardioversion or vasopressors.
Four (2%) low-risk (GBS ≤7) patients required MB
transfer within the first 48 hours (table 3). Three transfers

Table 2 Low-risk patients with GBS 5–7 admitted to
different units
Unmonitored Monitored
bed
bed
No

P value

109

25

Median age

68

67

0.91

Female

40%

42%

0.98

6.3

0.45

Average GBS
LOS (av in hours)

6.2
71

Underwent urgent
endoscopy

76 (70%)

91

0.14

17 (68%)

0.98

Required transfusion

17 (16%)

6 (24%)

0.38

Experienced rebleed

8 (7%)

3 (12%)

0.43

Radiographic or
surgical intervention

1 (1%)

1 (4%)

0.35

Death

1 (1%)

1 (4%)

0.35

GBS, Glasgow-Blatchford Bleeding Score; LOS, length of stay.

were made out of caution based on new findings and were
discharged home within 2 days. One patient ultimately
died due to mesenteric ischaemia despite intubation and
aggressive support. None of these patients experienced
recurrent bleeding.
He was one of 5 (2%) low-risk patients who died during
an admission for UGIB (table 4). All of these patients
were elderly and/or had significant underlying illness.
Three were had ‘do not resuscitate’ orders or were under
palliative care plans at admission. None of these deaths
appeared to have directly resulted from GI bleeding.
High-
risk patients (GBS ≥8) admitted to MBs did
not differ significantly from those admitted to UMB in
terms of age or gender but did a tend to have a higher
average GBS (11.8 vs 10.3 p<0.01). Patients admitted to
MBs tended to have a longer length of stay, require blood
transfusions and rebleed. Despite this, death rates were
similar (table 5).
Ten (6.7%) high-risk patients initially admitted to an
UMB required transfer to an MB (table 6). Two (1.3%)
eventually died. An 80-year-old man with a GBS of 10 died
of aspiration and sepsis. A review suggested that closer
monitoring and care from the outset may have prevented
this. A 50-year-old woman with a GBS of 9 died of encephalopathy and liver failure despite timely transfer to MB
and intubation. The most common reason for transfer
was respiratory failure (50%).
DISCUSSION
GI bleeding represents the most common cause for
admission to hospital GI services in the USA, accounting
for up to 500 000 admissions per year8 with 1.9% all-cause
mortality.9 Many UGIB patients present with some degree
of haemodynamic instability. Uncertainty about the
source of bleeding combined with the spectre of rapid
deterioration can lead to ICU admission. Most of these
patients however never need specialised ICU services
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Table 3 Low-risk (GBS ≤7) patients who were transferred to MB within first 48 hours
Age

Gender

GBS score

Reason for transfer

Outcome

68
30

F
F

4
7

New atrial fibrillation
Varices banded at endoscopy

Discharge home
Discharge home

77
64

F
M

3
4

Oesophageal ulcer at endoscopy
Lactic acidosis, severe vascular disease

Discharge home
Death

F, female; GBS, Glasgow-Blatchford Bleeding Score; M, male; MB, monitored bed.

such as intubation, central monitoring or urgent cardioversion. ICU and other MBs demand significantly more
resources than UMBs and may be a scarce commodity in
some hospitals. Admission to an ICU may also lead to more
invasive procedures and longer length of stay, without
necessarily producing better outcomes.2 ICU admissions
for UGIB vary widely in the USA. A recent study of 94
acute care, non-federal hospitals showed that ICU admission rates for UGIB ranged from 11.5% to 51.2%, without
any demonstrable difference in mortality.2 Another study
estimated that up to 40% of ICU admissions for UGIB are
unnecessary.10
In our own institution, the expense of (not charge
for) an ICU bed is about 2.5 times that of an UMB. A
step-down or IMCU bed is almost as expensive at about
twice the price of an UMB. This is driven largely by
higher staffing costs for both units. The level of care in
the Swedish IMCU resembles ICU care in many hospitals
with large, glass fronted individual rooms with central,
remote monitoring and patient to nurse ratios that do
not exceed 3:1. In fact, IMCU and ICU rooms are identical and differ in designation only when staffing levels
change. In this study, because of the similar costs and level
of care provide in ICU and IMCU and frequent shifting of
patients between the two units for non-medical reasons,
we chose to combine admissions to these two units and
compare them to admissions to UMBs, specifically for
lower-risk patients. Most patients in this study who were
admitted to MBs were actually admitted to IMCU rather
than ICU (315 vs 75 or 81%). We felt that because of the
broad variation in design and staffing of ICUs and other
MBs among different institutions, a clearer distinction in

cost and care could be drawn between monitored and
UMBs rather than among multiple different levels of
monitoring and care. The goal was not so much to determine whether the GBS identifies an ideal level of care
for each person, but rather to see if a score exists below
which monitored care may not be necessary.
The decision to direct patients with a GBS ≤7 to an UMB
was not arbitrary. Preventing morbidity and mortality
that might result from haemodynamic compromise
remains the primary goal of admitting UGIB patients
to an MB. A patient in an MB can receive rapid transfusion and fluid replacement, vasopressor support and
in extreme cases, undergo intubation and cardioversion.
In addition, close nursing support and constant haemodynamic monitoring can theoretically identify sequalae
of bleeding more rapidly. But studies suggest that rapid
blood loss is unlikely at GBS ≤7. Bryant et al11 reviewed 888
patients with UGIB and found no patient who needed
endoscopic or surgical intervention had an admission
GBS below 8. Chatten et al12 reviewed 399 patients with
UGIB and found that over 92% of patients with a GBS
≤8 did not need endoscopic therapy. Robertson et al13 in
a study of 424 patients with UGIB suggested that a GBS
of 9 for requiring ICU admission (88% sensitive and
44% specific) and a score of 10 was 76% sensitive and
86% specific for needing transfusion. A cut-off of 7 was
felt to exclude the vast majority of patients with active,
haemodynamically significant bleeding requiring aggressive support. Ready access to endoscopic diagnosis and
intervention for patients in UMBs as well as ability to
rapidly transfer deteriorating or unstable patients to an
MB provided additional reassurance. Internal review of

Table 4 Low-risk (GBS ≤7) patients who died during admission for UGIB

Age

Gender

GBS score

Initial admission

Length of
hospitalisation
(in days)

64
88

M
M

4
4

UMB
UMB

2
7

Mesenteric ischaemia
Aspiration pneumonia

Full Code
DNR

88

M

6

UMB

3

Congestive heart failure

DNR

66

F

7

MB

7

Full Code

86

M

7

MB

2

Cirrhosis, COPD,
respiratory failure
Oesophageal cancer,
aspiration pneumonia

Cause of death

Code status

DNR

COPD, chronic obstructive pulmonary disease; DNR, do not resuscitate; F, female; GBS, Glasgow-Blatchford Bleeding Score; M, male; MB,
monitored bed; UGIB, upper gastrointestinal bleeding; UMB, unmonitored bed.
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Table 5 High-risk patients (GBS ≥8) admitted to different
units
Unmonitored
bed
No
Median age

149
75

Monitored
bed
361
71

P value
0.14

Female

52%

49%

0.80

Average GBS

10.3

11.8

0.01

LOS (average in
hours)

94

Underwent urgent
endoscopy

135

0.05

125 (84%)

329 (91%)

0.57

Required
transfusion

77 (52%)

279 (77%)

0.01

Experienced
rebleed

10 (7%)

64 (18%)

0.02

Radiographic
or surgical
intervention
Death

3 (2%)

17 (5%)

0.22

5 (3%)

15 (4%)

0.78

GBS, Glasgow-Blatchford Bleeding Score; LOS, length of
stay.

6 months of patient with GBS ≤7 also suggested safety at
this level.
This study demonstrates that the GBS can identify a
threshold below which the likelihood of sudden deterioration from bleeding is very low. In the study population,
low-risk patients accounted for about a third of those
admitted with UGIB. Despite guidelines, 12% of low-risk
patients were admitted to MBs. Caution appears to have
driven most of these decisions. Despite a higher level of
care, the treatments and outcomes for these patients did
not differ significantly from those admitted to UMBs.
Two patients required intubation yet both died. It is
impossible to tell if any of the surviving patients benefited from the higher level of nursing care or haemodynamic monitoring. While five low-risk patients ultimately

died and four others were transferred to MBs, none was
the direct result of bleeding. It is not surprising and ultimately appropriate that some very elderly patients or
those with terminal conditions were not placed in MBs
as aggressive interventions would likely not have changed
outcomes. Transfers to MBs that did occur were timely
and no adverse outcomes appeared to have resulted from
primary UMB placement.
The GBS alone proved less effective for identifying
those who truly need an MB. Evidence-based guidelines
have suggested that haemodynamically unstable patients
and those with GBS ≥12 may benefit from endoscopy as
early as 12 hours after admission.14–17 Although formal
guidelines for ICU care for this group are lacking, it
might be assumed that patients unstable enough to
benefit from very early endoscopy would also benefit
from the highest level of care. However, a small subgroup
of 16 patients with a GBS ≥13 did as well in UMBs as those
in MBs. These patients tended to have higher scores due
to renal failure or severe anaemia but were otherwise
haemodynamically stable.
Roughly half of all UGIB patients had a GBS between
8 and 12. One-third of these patients did well in UMBs
and likely others would have as well. However, 10 (8%)
patients in this group, initially felt by the ER physician
to be low risk, required transfer to an MB. Four had
respiratory compromise or aspiration while two developed mental status changes associated with alcohol withdrawal or cirrhosis. Two of these patients ultimately died
but neither from ongoing bleeding. Seven other deaths
occurred among patients with scores between 8 and 10,
despite primary admission to an MB. This is consistent
with the findings of other studies that UGIB patients at
highest risk of mortality suffer from comorbidities such as
alcohol withdrawal, cirrhosis, and cancer6 and rarely die
directly from bleeding.18 The large number of high-risk
patients (32%) who were successfully treated in UMBs
suggests that other factors not captured by the GBS such
as age, alcohol withdrawal or respiratory compromise
should be considered when making bed selection and

Table 6 High-risk (GBS ≥8)) patients initially admitted to an UMB who were transferred to MB within 48 hours
Age

Gender

GBS score

Reason for transfer

Outcome

83
74

F
F

9
9

Respiratory compromise
Recurrent bleeding

Discharge home
Discharge home

50

F

9

Liver and respiratory failure

Death

92

M

10

Respiratory compromise, CHF

Discharge home

78

F

10

Persistent anaemia and arrhythmia

Discharge home

48

M

10

Alcohol withdrawal, encephalopathy

Discharge home

56

M

10

Alcohol withdrawal, aspiration

Discharge home

80

M

10

Aspiration pneumonia

Death

43
75

M
F

10
12

Large duodenal ulcer at endoscopy
Recurrent bleeding

Discharge home
Discharge home

CHF, congestive heart failure; F, female; GBS, Glasgow-Blatchford Bleeding Score; M, male; MB, monitored bed; UMB, unmonitored bed.
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that the absence of these conditions may enable safe
UMB placement for UGIB patients with a GBS ≥8. What
the safe GBS upper limit might be and what other factors
may be necessary predict safe UMB placement are not
identified in this study.
While risk assessment tools aid ICU decision making
for other conditions,19–21 none of the half dozen
common risk tools for GI bleeding are widely used for
this purpose.12 22 23 The Rockall Score, Baylor Bleeding
Score and Cedars-Sinai Predictive Index rely in part on
endoscopic elements that are generally not available to
the ER physician.24 The GBS, the AIMS65 score as well as
the clinical Rockall score rely only on vital signs, labs and
historical elements that are almost always available in the
first hours of evaluation. The GBS has been shown to help
predict need for urgent endoscopy13 and blood transfusion,20 two factors that might suggest a need for higher
level of care,5 but has not been previously reported as
a tool for bed assignment. The GBS remains the most
widely studied risk stratification tool for UGIB and
appears to be more sensitive than either of the Rockall
scores.4 20
The AIMS65 score, which incorporates age and
albumin level but not subjective or historical elements
like syncope and liver disease, appears to be more accurate for predicting mortality and length of stay,25 but
may be less accurate than the GBS for predicting recurrent bleeding or transfusion requirement.26 27 However,
predicting death in patients with advanced age and
multiple comorbidities may not clearly translate into
better outcomes with early MB admission. The AIMS65
score is easier to memorise and calculate than the GBS,
but this advantage fades when the EHR automates it.
Despite recommendations to incorporate them into
decision making in the ER, risk scores are not used
widely.1 Many physicians feel that risk scores are not
particularly useful or don’t work any better than an ER
physician’s judgement.28 29 It may also be that even simple
scores require too much effort to remember and apply
than most busy physicians are willing to invest.
This study shows that by leveraging the data grabbing
functions of an EHR, the GBS can be easily incorporated
into the ER assessment. But even this feature did not lead
to rapid adoption. Only after months of intense education did ER physicians begin to use the GBS calculator
regularly, and even then, not consistently. However, once
adopted, the GBS began to serve as an efficient short
hand among ER physicians, hospitalists and gastroenterologists, replacing a long list of vital signs and labs with a
simple, widely understood number.
Because the source of GI bleeding is often unclear at
presentation, the ideal risk score would have utility for
LGI bleeding as well. While several scores have been
proposed to predict mortality and other outcomes
for patients with LGI bleeding, studies have emerged
showing that the GBS has reasonable accuracy for identifying low-
risk patients with LGI bleeding.30 31 This
study supports those findings and demonstrates that the
6

GBS may effectively identify low-risk patients with LGI
bleeding safe for UMBs. A total of 244 patients who were
ultimately found to have had lower GI bleeding had a
bleeding score calculated at admission. The GBS directed
117 of 133 (88%) low-risk patients to UMBs. None of
these patients suffered an adverse event or poor outcome
as a result of their bed placement. Four low-risk patients
were transferred to MBs within 48 hours. Three who were
transferred out of caution due to cirrhosis, alcohol withdrawal and ongoing bleeding were discharged within
48 hours of transfer. One patient with a diverticular
source continued to bleed despite angiography and ultimately underwent haemicolectomy.
Any cost savings from using the GBS remains unknown.
An earlier review at our institution of 166 UGIB patients
revealed that using the GBS along with other elements
aimed at improving physician communication decreased
ICU admissions by 42%, LOS by 14% and hospital
expense by 18%.7 Chang and Shapiro estimated that if
ICU care for UGI bleeding patients in higher utilisation
hospitals were reduced to levels of lower utilisation hospitals, total costs would drop by about 6.5%.2
Several elements limit this study. First, the GBS for
bed placement is limited because it does not take into
account comorbidities and risk factors beyond GI
bleeding. Many low-risk patients were admitted to MBs
based on ER physicians’ concerns about other conditions and less than a third were redirected based on a
concern about bleeding. Two who died succumbed to
respiratory complications without rebleeding and none
in this group needed aggressive haemodynamic interventions to control bleeding. But there is no way of
knowing whether this small group would have done as
well in UMBs. However, this does demonstrate the real
world applicability of these guidelines; physicians had no
problem admitting outside of guidelines when a patient
appeared at higher risk.
Just under a fifth of patients with signs of UGI bleeding
did not undergo endoscopy during the index admission.
Although all had a diagnostic endoscopy within the last
year, the true cause of these bleeds was not documented.
The number and types of endoscopic interventions are
also not captured in this data, nor are the final diagnoses,
incidence of liver disease and bleeding source for all
patients. While more granular data may help us better
understand which patients are ultimately more likely to
rebleed or do poorly, the source of the bleed is almost
always obscure at the time of admission and the presence of cirrhosis may also be unknown. The ideal risk
score should aid in placement without having to know
the source of bleeding if no diagnostic or interventional
endoscopy is necessary. In this study, two individuals in
the lower-risk group were admitted to MBs because of a
concern for varices and one other who was found to have
non-bleeding varices after index endoscopy was transferred to the ICU for observation. Others may have had
cirrhosis that was not initially identified but did not lead
to deterioration or require MB transfer.
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During the study period, up to 37% of patients with
UGIB may have been missed because some ER physicians did not use the automated system. However, it does
not appear that any specific risk groups were excluded.
This suggests that, although incomplete, the cohort was
representative of patients who present with UGIB. The
study also does not look at hospital readmissions or
post hospital deaths, although an adverse effect from
improper bed placement would likely become apparent
during that admission and not after discharge. Some
subgroup analyses involve small numbers of patients,
limiting the ability to demonstrate differences.
The findings of this study may not be universally applicable. Hospitals, their staffs and their skill sets differ.
While patients with a score of 7 may consistently do well
in an UMB at a facility where access to endoscopy is easy
and ICU beds plentiful, the same may not be true for
smaller hospitals with fewer ICU beds and inconsistent
specialty coverage. Similarly, some facilities may not have
ready access to a 24-hour endoscopy unit and depend
on MBs for urgent endoscopy. Although it appears that
a GBS ≤7 predicts a low risk of deterioration, a hospital’s
unique profile and ability to manage these problems
should determine cut-
off levels for MB placement or
transfer.

CONCLUSION
This study demonstrates that UGIB patients with a GBS≤7
in the ER should be admitted to UMBs in the absence of
other major comorbidities or signs of rapid deterioration.
The ease with which EHRs can incorporate the score into
ER workflows suggests that greater use and acceptance
of the tool could reduce unnecessary MB admissions. In
its current form, the GBS lacks the precision to serve as
the sole determinant of bed placement for higher-risk
patients.
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